Le Lézard
Classified in: Health, Covid-19 virus
Subjects: NPT, FVT

Canada's blood cancer community to unite at Light The Night, Take Back The Light virtual event amid pandemic


TORONTO, Oct. 19, 2020 /CNW/ - More than 50, 000 people from across the country are expected to take part in Light The Night, Take Back The Light ? an annual flagship event hosted by The Leukemia & Lymphoma Society of Canada (LLSC). For the first time in the organization's history, the event will be broadcast nationally on October 24th at 7 pm EST and Canadians who are immunocompromised, like those newly diagnosed and people in treatment, will be able to participate and engage with the blood cancer community in real time. Due to the pandemic, Light The Night will look different, but it will feel the same as communities from across the country come together virtually to honour and remember those touched by a blood cancer.

"Every 23 minutes, someone is diagnosed with a blood cancer in Canada," says Alicia Talarico, LLSC's president. "Light The Night can help to ensure that in a time of pandemic, Canada's blood cancer community is not left behind, and that we can continue to deliver critical programs and services, and invest in research that saves lives."

Now in its 16th year, Light The Night will raise awareness and funds for blood cancer research and critical programs and services that support Canadians at every step of their blood cancer experience. This year, technology will bring participants together to share stories, remember loved ones lost and pay tribute to those facing a blood cancer. Light The Night generates the lion's share of funds for blood cancer research and in 2019, event participants raised $6.6 million.

"A blood cancer diagnosis can impact physical, emotional and mental health," says Nadine Prevost, director of community services at the LLSC. "Connecting virtually with others can help those newly diagnosed and people in treatment maintain a sense of community and support, lift their spirits and assist in the recovery process."

LLSC is the leading non-profit voluntary health organization dedicated to finding cures for blood cancers and ensuring that patients have access to life-saving treatments. Each year, more than 23,000 Canadians are diagnosed with a form of blood cancer. Through its fundraising programs, LLSC has invested more than $40 million in research to better understand the underlying causes of the disease, develop better therapies, and save more lives. The funds raised through Light The Night Walk will be used for:

There are many ways to raise awareness and show support for Canadians affected by blood cancers. Visit the Light The Night website at LightTheNight.ca to donate and learn more. Broadcast will be streamed on YouTube, Facebook and LightTheNight.ca 

About Light The Night

Now in its 16th year, Light The Night, The Leukemia & Lymphoma Society of Canada's annual flagship event unites the blood cancer community in celebration, remembrance and hope. In 2019, over $6.6 million was raised in support of research and critical programs. While Canadians will not be walking together this year due to COVID-19, Light The Night Fundraising Teams are actively working to raise money for the blood cancer community. To celebrate their achievements, honour community heroes and remember loves ones lost, The Leukemia & Lymphoma Society of Canada will host a national Light The Night virtual event on October 24, 2020 at 7pm EST. To learn more, visit LightTheNight.ca

Follow the hashtag for updates: #TakeBackTheLight #LightTheNight #endbloodcancers

About The Leukemia & Lymphoma Society of Canada

The Leukemia & Lymphoma Society of Canada (LLSC) is the single largest voluntary health agency dedicated to blood cancers in Canada. LLSC funds life-saving blood cancer research across the country, and provides information and support services free of charge to people affected by a blood cancer and their families. Our mission is to cure leukemia, lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of Canadians affected by blood cancers.

For personalized disease, treatment or support information, contact our local support staff at 1-833-222-4884. Follow us on FacebookTwitter and Instagram. Visit llscanada.org for more.

SOURCE The Leukemia & Lymphoma Society of Canada


These press releases may also interest you

at 01:00
PARIS, FRANCE, 24 April 2024 - Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-care biopharmaceutical company, today presents its sales for the first quarter of 2024. ? ?  Q1 2024? Q1 2023? % change? ?m? ?m? ActualCER1Growth...

23 avr 2024
GenScript, a global leader in life sciences and biotechnology, successfully hosted an Open Day event at its Singapore facility on the 16th of April, welcoming more than 50 representatives from Singapore. This event provided an exclusive look into...

23 avr 2024
Cybervation, an award-winning global technology and healthcare solutions company, proudly announces that its CEO, Purba Majumder, has been distinguished as one of the 2024 100 Women to KNOW Across America. This award from KNOW Women recognizes...

23 avr 2024
The report titled "Glycated Albumin Assay Market by Product (Animal Glycated Albumin Assay, Human Glycated Albumin Assay), Application (Prediabetes, Type 1 Diabetes, Type 2 Diabetes), End User - Global Forecast 2024-2030" is now available on...

23 avr 2024
The report titled "Health & Wellness Food Market by Type (Fresh & Natural, Functional Foods & Beverages, Heat & Eat), Nature (Genetically Modified Organism Food, Non-Genetically Modified Organism Food), Fat Content, Category, Free From Category,...

23 avr 2024
Hanmi Pharmaceutical (KOSPI: 128940, CEO: Jae-Hyun Park), a leading biopharma company in Korea that focuses on research areas such as oncology, obesity/metabolism, and rare diseases, announced it has entered into a Clinical Trial Collaboration and...



News published on and distributed by: